Omalizumab superior to oral immunotherapy for multifood allergy, and most patients consume allergy-triggering foods after gaining tolerance.
Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract ...
Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...
14h
Medpage Today on MSNBiologic May Spark Catch-Up Growth in Kids With EczemaBiologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis ...
Early dietary diversity in infants may reduce the risk of food allergies by promoting immune tolerance and gut microbiome ...
Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...
"The effect of formula supplementation spans beyond cow's milk allergy," Bhasin said, citing a prior randomized trial showing ...
Patients with multiple food allergies introduced allergens into their diets after using omalizumab, researchers reported at ...
Obesity worsens asthma severity and responses to medication, yet most doctors fail to address weight management with these ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Pope Francis suffered two episodes of acute respiratory distress Monday as his prognosis remains "guarded" while at a hospital in Rome, the Vatican announced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results